Data From REMEDEE Trial Featuring OrbusNeich's Combo(TM) Dual Therapy Stent to ... MarketWatch (press release) 1, 2011 /PRNewswire via COMTEX/ -- OrbusNeich today announced that data from REMEDEE (Randomized Evaluation of an abluMinal sirolimus coatED bio-Engineered stEnt), a randomized clinical trial of the Combo Bio-engineered Sirolimus Eluting Stent (Combo ... Data From REMEDEE Trial Featuring OrbusNeich's Combo™ Dual Therapy Stent to ... |
